Invest in some of the most exciting and disruptive developments in the fight against cancer.

Enter your details below for more information

De-risked and asset backed investing

Invest in hand-picked Oncological companies that have demonstrated proof of technical, clinical and market value.

• Asset-backed and de-risked investment

• Major displacing technology

Investment Highlight:

• Long patent protection

• Experienced and competent management

• Target returns of 400% - 750%

• Targeting 18 month returns

• Investment is by purchase of Redeemable Preference Shares (RPSs)

• Realistic forecast returns are based on comparables

Disclaimer: Investment in an unlisted company always carries a higher risk. If you are unsure whether an investment is suitable for your circumstances, you should consult an FCA-authorised Independent Financial Adviser. This page does not offer personal advice. This investment is reserved for suitable investors that are either; a high net worth individual, a sophisticated investor, an Investment Professional or a representative of a high net worth company, trust, partnership or association.